BIMU-1
500 mg
| Purity Not Available
TargetMol
TargetMol
Bindarit displays specific inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.
More Information
Supplier Page
TargetMol
Bindarit displays specific inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.
More Information
Supplier Page
TargetMol
Bindarit displays specific inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.
More Information
Supplier Page
TargetMol
Bindarit displays specific inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.
More Information
Supplier Page
TargetMol
Bindarit displays specific inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.
More Information
Supplier Page
TargetMol
Bindarit displays specific inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.
More Information
Supplier Page
TargetMol
Bindarit displays specific inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.
More Information
Supplier Page
TargetMol
Bindarit displays specific inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.
More Information
Supplier Page
TargetMol
Bindarit displays specific inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.
More Information
Supplier Page
Binedaline
5 mg
| Purity Not Available
TargetMol
Binedaline
50 mg
| Purity Not Available
TargetMol
Binedaline
100 mg
| Purity Not Available
TargetMol
Binfloxacin
5 mg
| Purity Not Available
TargetMol
Binifibrate
5 mg
| Purity Not Available
TargetMol
Binifibrate
50 mg
| Purity Not Available
TargetMol
Binifibrate
100 mg
| Purity Not Available
TargetMol
Binimetinib
100 mg
| Purity Not Available
TargetMol
Binimetinib (MEK162, ARRY-162, ARRY-438162) is an orally available inhibitor of MEK1/2 (IC50: 12 nM) in a cell-free assay.
More Information
Supplier Page
Binimetinib
200 mg
| Purity Not Available
TargetMol
Binimetinib (MEK162, ARRY-162, ARRY-438162) is an orally available inhibitor of MEK1/2 (IC50: 12 nM) in a cell-free assay.
More Information
Supplier Page
Binimetinib
1 mL
| Purity Not Available
TargetMol
Binimetinib (MEK162, ARRY-162, ARRY-438162) is an orally available inhibitor of MEK1/2 (IC50: 12 nM) in a cell-free assay.
More Information
Supplier Page
Binimetinib
10 mg
| Purity Not Available
TargetMol
Binimetinib (MEK162, ARRY-162, ARRY-438162) is an orally available inhibitor of MEK1/2 (IC50: 12 nM) in a cell-free assay.
More Information
Supplier Page
Binimetinib
25 mg
| Purity Not Available
TargetMol
Binimetinib (MEK162, ARRY-162, ARRY-438162) is an orally available inhibitor of MEK1/2 (IC50: 12 nM) in a cell-free assay.
More Information
Supplier Page
Binimetinib
50 mg
| Purity Not Available
TargetMol
Binimetinib (MEK162, ARRY-162, ARRY-438162) is an orally available inhibitor of MEK1/2 (IC50: 12 nM) in a cell-free assay.
More Information
Supplier Page
Binimetinib
5 mg
| Purity Not Available
TargetMol
Binimetinib (MEK162, ARRY-162, ARRY-438162) is an orally available inhibitor of MEK1/2 (IC50: 12 nM) in a cell-free assay.
More Information
Supplier Page
TargetMol
Binodenoson is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging[1].
More Information
Supplier Page
TargetMol
Binodenoson is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging[1].
More Information
Supplier Page
TargetMol
Binodenoson is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging[1].
More Information
Supplier Page
TargetMol
Binodenoson is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging[1].
More Information
Supplier Page
TargetMol
Binodenoson is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging[1].
More Information
Supplier Page
TargetMol
Binodenoson is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging[1].
More Information
Supplier Page
TargetMol
Binodenoson is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging[1].
More Information
Supplier Page
TargetMol
TargetMol
TargetMol
Binucleine 2
5 mg
| Purity Not Available
TargetMol
Binucleine 2 is an isoform-specific and ATP-competitive inhibitor of Drosophila Aurora B kinase (Ki = 0.36 μM), a kinase involved in cell division. It is specific for Drosophila Aurora B kinase, inhibiting it in a dose-dependent manner, with minimal inhibition of human or X. laevis Aurora B kinases at concentrations up to 100 μM. Binucleine […]
More Information
Supplier Page
Binucleine 2
50 mg
| Purity Not Available
TargetMol
Binucleine 2 is an isoform-specific and ATP-competitive inhibitor of Drosophila Aurora B kinase (Ki = 0.36 μM), a kinase involved in cell division. It is specific for Drosophila Aurora B kinase, inhibiting it in a dose-dependent manner, with minimal inhibition of human or X. laevis Aurora B kinases at concentrations up to 100 μM. Binucleine […]
More Information
Supplier Page
Binucleine 2
100 mg
| Purity Not Available
TargetMol
Binucleine 2 is an isoform-specific and ATP-competitive inhibitor of Drosophila Aurora B kinase (Ki = 0.36 μM), a kinase involved in cell division. It is specific for Drosophila Aurora B kinase, inhibiting it in a dose-dependent manner, with minimal inhibition of human or X. laevis Aurora B kinases at concentrations up to 100 μM. Binucleine […]
More Information
Supplier Page
BIO-013077-01
1 mg
| Purity Not Available
TargetMol
BIO-013077-01
5 mg
| Purity Not Available
TargetMol
BIO-013077-01
10 mg
| Purity Not Available
TargetMol
BIO-013077-01
25 mg
| Purity Not Available
TargetMol
BIO-013077-01
1 mL
| Purity Not Available
TargetMol
BIO-013077-01
50 mg
| Purity Not Available
TargetMol
BIO-013077-01
100 mg
| Purity Not Available
TargetMol
TargetMol
BIO-11006 acetate salt is a polyglycosylated alanine rich C kinase substrate (MARCKS) inhibitor similar to MANS peptides.
More Information
Supplier Page
TargetMol
BIO-11006 acetate salt is a polyglycosylated alanine rich C kinase substrate (MARCKS) inhibitor similar to MANS peptides.
More Information
Supplier Page
TargetMol
BIO-11006 acetate salt is a polyglycosylated alanine rich C kinase substrate (MARCKS) inhibitor similar to MANS peptides.
More Information
Supplier Page
TargetMol
BIO-11006 acetate salt is a polyglycosylated alanine rich C kinase substrate (MARCKS) inhibitor similar to MANS peptides.
More Information
Supplier Page
TargetMol
BIO-11006 acetate salt is a polyglycosylated alanine rich C kinase substrate (MARCKS) inhibitor similar to MANS peptides.
More Information
Supplier Page
TargetMol
BIO-11006 acetate salt is a polyglycosylated alanine rich C kinase substrate (MARCKS) inhibitor similar to MANS peptides.
More Information
Supplier Page